TORRANCE, Calif., June 26, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration ...
The treatment is supplied in packets containing 5g of L-glutamine powder. A generic version of Endari ® (L-glutamine oral powder) has been made available by ANI Pharmaceuticals. L-glutamine oral ...
Endari (L-glutamine) is a brand-name oral powder that’s prescribed to reduce complications of sickle cell disease in adults and some children. As with other drugs, Endari can cause side effects, such ...
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback